Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Rang in aandelen #26460
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Aandeelprijs
$2.70
Marktkapitalisatie
$40.42M
Verandering (1 dag)
-1.28%
Verandering (1 jaar)
-48.17%
Land
US
Handel Serina Therapeutics, Inc. (SER)

Categorie

Dividendrendementgeschiedenis voor Serina Therapeutics, Inc. (SER)
Het dividendrendement (TTM) van Serina Therapeutics, Inc. (aandelsymbool: SER) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Serina Therapeutics, Inc. (SER) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
US